Northwire Canada EditionTuesday, August 25, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% NVO 0.070 +0.0% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0% GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% NVO 0.070 +0.0% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0%
Earnings Routine +

High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

First net income and record EBITDA beat expectations, but same-store sales decline and flat price action suggest skepticism remains.

By The Northwire Desk — AI Analysis Jun 15, 2026 · 16:00 HITI · 3.23 High Tide Inc.
Executive Summary
  • Q2 FY2026 revenue reached $179.3M (+30% YoY, +1% QoQ).
  • Adjusted EBITDA hit a record $13.9M (+73% YoY).
  • Company reported its first positive net income ($0.024M), reversing a $2.8M loss YoY.
  • Free cash flow generated was $1.5M, down from $4.9M YoY due to working capital investments.
  • Consolidated gross margin reached 27%, an eight-quarter high (+200 bps QoQ).
  • Remexian (German medical cannabis) generated record segment revenue of $31.6M (+49% YoY) with gross margins doubling to 27% from 12% in Q1.
  • Canna Cabana retail same-store sales declined 1.2% YoY but outperformed peers; shrink improved to 0.2%.
  • Secured a $40M senior secured credit facility from Bank of Montreal to refinance existing debt and fund growth.
  • Acquired Northern Helm for $7.74M (4 Ontario stores) at 4.5x annualized adjusted EBITDA.
  • Insiders purchased 90,882 shares at an average of $3.39.
Material Impact
  • The news is positive but routine. The record EBITDA beat and first net income are operationally sound, driven by the Remexian margin expansion and cost controls. However, the 1.2% decline in same-store sales signals potential retail saturation or competitive pressure in Canada. The stock's -3.9% move into the print indicates skepticism was already discounted. The market likely viewed the retail top-line deceleration as a drag that offsets the EBITDA beat. There is no fundamentally new catalyst to re-rate the business; the execution is steady but not transformative.
HITI · Price
Company Overview
  • High Tide operates Canna Cabana, the largest cannabis retail chain in Canada with 221 locations, and Remexian Pharma, a leading medical cannabis distributor in Germany. The company leverages a membership ecosystem (Cabana Club and ELITE) and a discount club model to drive customer loyalty and market share. It is also exploring expansion into the U.K. and U.S. CBD markets.
Read the original news release →

More from High Tide Inc.

Jun 17, 2026 · 06:00

Remexian distribution partnerships reinforce German growth thesis, but stock has already priced in the catalyst.

M&A / Property Jun 15, 2026 · 15:31

High Tide receives approval for $40M of facilities

Financings Jun 15, 2026 · 06:00

High Tide to Acquire Northern Helm, Adding Four Established Retail Cannabis Stores in Ontario

M&A / Property Jun 10, 2026 · 11:00

Routine store expansion in line with guidance; market remains skeptical as stock drifts lower post-Q1 beat.

Production / Operations May 11, 2026 · 06:00

Insider buying and surging German medical cannabis market share signal conviction as High Tide shores up a Big Five bank credit line.

Production / Operations May 06, 2026 · 06:00

High Tide Germany Distribution Surges as Bank Financing Validates Liquidity

Production / Operations